FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wim Oyen

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Living Beings

Mouse
Rats

Disorders

Co-author Network

Publications

TOP 3
Sandra Heskamp; Janneke D M Molkenboer-Kuenen; Wim J G Oyen; Winette T A van der Graaf; Otto C Boerman; Hanneke W M van Laarhoven
Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies.
Constantijn H J Muselaers; Egbert Oosterwijk; Wim J G Oyen; Otto C Boerman; Johannes F Langenhuijsen; Peter F A Mulders
Indium-111-labeled Girentuximab ImmunoSPECT as a Diagnostic Tool in Clear Cell Renal Cell Carcinoma.
Ingrid Dijkgraaf; Gerben M Franssen; David M Goldenberg; Peter Laverman; William J McBride; Wim J G Oyen; Samantha Y A Terry; Otto C Boerman
Imaging integrin alpha-v-beta-3 expression in tumors with an (18) F-labeled dimeric RGD peptide.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wim Oyen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sandra Heskamp; Janneke D M Molkenboer-Kuenen; Wim J G Oyen; Winette T A van der Graaf; Otto C Boerman; Hanneke W M van Laarhoven
Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies.
International journal of cancer. Journal international du cancer 2013;133(2):307-14.
2013: Constantijn H J Muselaers; Egbert Oosterwijk; Wim J G Oyen; Otto C Boerman; Johannes F Langenhuijsen; Peter F A Mulders
Indium-111-labeled Girentuximab ImmunoSPECT as a Diagnostic Tool in Clear Cell Renal Cell Carcinoma.
European urology 2013;63(6):1101-6.
2013: Ingrid Dijkgraaf; Gerben M Franssen; David M Goldenberg; Peter Laverman; William J McBride; Wim J G Oyen; Samantha Y A Terry; Otto C Boerman
Imaging integrin alpha-v-beta-3 expression in tumors with an (18) F-labeled dimeric RGD peptide.
Contrast media & molecular imaging 2013;8(3):238-45.
2013: Bianca A W Hoeben; Johan Bussink; Wim J G Oyen; Paul N Span; Esther G C Troost; Carla M L van Herpen; Johannes H A M Kaanders
18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013;54(4):532-40.
2013: Jurjen Tel; Michelle van Rossum; Gregor Winkels; E H J G Aarntzen; Tetsuro Baba; Daniel Benitez-Ribas; Otto C Boerman; Pierre G Coulie; Sandra Croockewit; Carl G Figdor; Wim J G Oyen; Cornelis J A Punt; Gerty Schreibelt; Barbara M Schulte; I Jolanda M De Vries
Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients.
Cancer research 2013;73(3):1063-75.
2012: E H J G Aarntzen; Jeff W M Bulte; I Jolanda M De Vries; Carl G Figdor; Arend Heerschap; Miroslaw Janowski; Mangala Srinivas; Piotr Walczak; Wim J G Oyen
In vivo tracking techniques for cellular regeneration, replacement, and redirection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(12):1825-8.
2012: Rafke Schoffelen; Robert M Sharkey; Winette T A van der Graaf; Desirée L Bos; Chien-Hsing Chang; Gerben M Franssen; David M Goldenberg; William J McBride; Wim J G Oyen; Otto C Boerman
Quantitative immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in an intraperitoneal nude mouse model of human colon cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(12):1926-32.
2012: Albert J S Idema; Esther G C Troost; Winette T A van der Graaf; Pieter Wesseling; Hieronymus D Boogaarts; J Andre Grotenhuis; Arend Heerschap; Aswin L Hoffmann; Wim J G Oyen
3'-Deoxy-3'-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(12):1904-10.
2012: Linda Heijmen; Wim J G Oyen; Cornelis J A Punt; Johan Bussink; Lioe-Fee de Geus-Oei; Johannes H W de Wilt; Mathieu Hatt; Eric P Visser; Dimitris Visvikis; Hanneke W M van Laarhoven
Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.
European journal of nuclear medicine and molecular imaging 2012;39(12):1858-67.
2012: Janneke Donckers; Maria T E Hopman; Fred K Lotgering; Wim J G Oyen; Ralph R Scholten; Marc E A Spaanderman
Unexplained first trimester recurrent pregnancy loss and low venous reserves.
Human reproduction (Oxford, England) 2012;27(9):2613-8.
2012: Linda Heijmen; John J Hermans; Wim J G Oyen; Cornelis J A Punt; Edwin E G W Ter Voert; Lioe-Fee de Geus-Oei; Arend Heerschap; Maartje C H M Verstappen; Hanneke W M van Laarhoven
Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use?
Critical reviews in oncology/hematology 2012;83(2):194-207.
2012: Susanne Lütje; Otto C Boerman; Wijnand Helfrich; Wim J G Oyen; Michiel Sedelaar; Catharina M van Rij; Peter F A Mulders
Prospects in radionuclide imaging of prostate cancer.
The Prostate 2012;72(11):1262-72.
2012: Ingrid Dijkgraaf; Christopher A D'Souza; Gerben M Franssen; David M Goldenberg; Peter Laverman; William J McBride; Wim J G Oyen; Charles J Smith; Otto C Boerman
PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(6):947-52.
2012: Ingrid M E Desar; Rozemarie Gilles; Anja J N H Timmer-Bonte; Winette T A van der Graaf; C M L van Herpen; Mireille V Cantarini; Wim J G Oyen
(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors.
World journal of nuclear medicine 2012;11(2):65-9.
2012: Anne I J Arens; Lioe-Fee de Geus-Oei; Baudewijn W Hendrickx; Berit M Verbist; Wim J G Oyen
False positive 18F-FDG PET/CT due to inflamed concha bullosa.
Clinical nuclear medicine 2012;37(5):509-10.
2012: Gabie M de Jong; Helena M Dekker; Martin Gotthardt; Thijs Hendriks; Roel D M Mus; Wim J G Oyen; Eric P Visser; Robert P Bleichrodt; Otto C Boerman
18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases.
Molecular imaging 2012;11(2):148-54.
2012: Dennis Vriens; Lioe-Fee de Geus-Oei; Jonathan A Disselhorst; Wim J G Oyen; Eric P Visser
Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET.
International journal of radiation oncology, biology, physics 2012;82(5):e725-31.
2012: Peter Laverman; William J McBride; Wim J G Oyen; Robert M Sharkey; Christopher A D'Souza; Annemarie Eek; David M Goldenberg; Otto C Boerman
Optimized labeling of NOTA-conjugated octreotide with F-18.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(2):427-34.
2012: Maarten Brom; Martin Gotthardt; Lieke Joosten; Wim J G Oyen; Otto C Boerman
Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas.
Contrast media & molecular imaging 2012;7(2):160-6.
2012: Fidel J Vos; Geert J A Wanten; Paul F M Krabbe; Bart Jan Kullberg; Wim J G Oyen; Patrick D Sturm; Arie P J van Dijk; Chantal P Bleeker-Rovers
Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia.
Medicine 2012;91(2):86-94.
2012: Esther Aarts; Bastiaan R Bloem; Rick C Helmich; Marcel J R Janssen; Wim J G Oyen; Roshan Cools
Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss.
NeuroImage 2012;59(4):3339-46.
2012: Peter Laverman; Otto C Boerman; Jane K Sosabowski; Wim J G Oyen
Radiolabelled peptides for oncological diagnosis.
European journal of nuclear medicine and molecular imaging 2012;39 Suppl 1():S78-92.
2012: Lioe-Fee de Geus-Oei; Martin Hutchings; Anne I J Arens; Dennis Vriens; Wim J G Oyen
FDG-PET/CT based response-adapted treatment.
Cancer imaging : the official publication of the International Cancer Imaging Society 2012;12():324-35.
2012: Fidel J Vos; Chantal P Bleeker-Rovers; J Peter Donnelly; Bart Jan Kullberg; Wim J G Oyen; Nicole M A Blijlevens
18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation.
European journal of nuclear medicine and molecular imaging 2012;39(1):120-8.
2011: E H J G Aarntzen; Willeke A M Blokx; Otto C Boerman; Johannes J Bonenkamp; Johannes H W de Wilt; Carl G Figdor; J F M Jacobs; W Joost Lesterhuis; Roel D Mus; Wim J G Oyen; Cornelis J A Punt; Mangala Srinivas; Esther G Troost; Michelle M van Rossum; Albert D Windhorst; I Jolanda M De Vries
Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(45):18396-9.
2011: Fidel J Vos; Eddy M M Adang; Chantal P Bleeker-Rovers; Bart Jan Kullberg; Wim J G Oyen
Cost-effectiveness of routine (18)F-FDG PET/CT in high-risk patients with gram-positive bacteremia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(11):1673-8.
2011: Dennis Vriens; Johannes H W de Wilt; RT Netea-Maier; Wim J G Oyen; Gert J van der Wilt; Lioe-Fee de Geus-Oei
The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature.
Cancer 2011;117(20):4582-94.
2011: Catharina M van Rij; Wietske M van Weerden; Gerben M Franssen; Cathelijne Frielink; David M Goldenberg; Janneke D M Molkenboer; Wim J G Oyen; Robert M Sharkey; Otto C Boerman
Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(10):1601-7.
2011: Anita A Harteveld; Antoi P W Meeuwis; Wim J G Oyen; Cornelis H Slump; Otto C Boerman; Jonathan A Disselhorst; Eric P Visser
Using the NEMA NU 4 PET image quality phantom in multipinhole small-animal SPECT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(10):1646-53.
2011: W Joost Lesterhuis; Sophie Lucas; Roel Mus; Wim J G Oyen; Cornelis J A Punt; Nicole M Scharenborg; Gerty Schreibelt; Mandy W M M van de Rakt; Michelle M van Rossum; Erik H J G Aarntzen; Gosse J Adema; Otto C Boerman; Sandra Croockewit; Annemiek J de Boer; I Jolanda M De Vries; J F M Jacobs; Annechien J A Lambeck; Carl G Figdor
Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(17):5725-35.
2011: Bianca A W Hoeben; Johannes H A M Kaanders; Janneke D M Molkenboer-Kuenen; Wim J G Oyen; Wenny J M Peeters; Johan Bussink; Otto C Boerman
Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model.
International journal of cancer. Journal international du cancer 2011;129(4):870-8.
2011: Jonathan A Disselhorst; Wim J G Oyen; Lioe-Fee de Geus-Oei; Dennis Vriens; Eric P Visser
Shortened dynamic (18)F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(8):1330; author reply 1330-1.
2011: Otto C Boerman; Wim J G Oyen
Immuno-PET of cancer: a revival of antibody imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(8):1171-2.
2011: Peter Laverman; Helmut R Mäcke; Theodosia Maina; Wim J G Oyen; Petra Kolenc Peitl; Jean-Claude Reubi; Susan Roosenburg; Jane K Sosabowski; Elisabeth von Guggenberg; Luigi Aloj; Marion De Jong; Annemarie Eek; Lieke Joosten; Otto C Boerman
Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides.
European journal of nuclear medicine and molecular imaging 2011;38(8):1410-6.
2011: Ingrid M E Desar; Christina A Hulsbergen-vandeKaa; Wim J G Oyen; Peter F A Mulders; Winette T A van der Graaf; Gosse J Adema; Carla M L van Herpen; J F M Jacobs; I Jolanda M De Vries
Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.
International journal of cancer. Journal international du cancer 2011;129(2):507-12.
2011: Stijn W T P J Heijmink; Jurgen J Fütterer; Stephen Strum; Wim J G Oyen; Ferdinand Frauscher; J Alfred Witjes; Jelle O Barentsz
State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer.
Acta oncologica (Stockholm, Sweden) 2011;50 Suppl 1():25-38.
2011: David Mönnich; Esther G C Troost; Johannes H A M Kaanders; Wim J G Oyen; Markus Alber; Daniela Thorwarth
Modelling and simulation of [18F]fluoromisonidazole dynamics based on histology-derived microvessel maps.
Physics in medicine and biology 2011;56(7):2045-57.
2011: Maarten Brom; Lieke Joosten; Peter Laverman; Wim J G Oyen; Martin Béhé; Martin Gotthardt; Otto C Boerman
Preclinical evaluation of 68Ga-DOTA-minigastrin for the detection of cholecystokinin-2/gastrin receptor-positive tumors.
Molecular imaging 2011;10(2):144-52.
2011: Lioe-Fee de Geus-Oei; Annelies M C Mavinkurve-Groothuis; Louise Bellersen; Martin Gotthardt; Wim J G Oyen; Livia Kapusta; Hanneke W M van Laarhoven
Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(4):560-71.
2011: Johan Bussink; Johannes H A M Kaanders; Winette T A van der Graaf; Wim J G Oyen
PET-CT for radiotherapy treatment planning and response monitoring in solid tumors.
Nature reviews. Clinical oncology 2011;8(4):233-42.
2011: Erik Vegt; Marleen Melis; Annemarie Eek; Monique de Visser; Maarten Brom; Wim J G Oyen; Martin Gotthardt; Marion De Jong; Otto Boerman
Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice.
European journal of nuclear medicine and molecular imaging 2011;38(4):623-32.
2011: Dennis Vriens; Lioe-Fee de Geus-Oei; Arend Heerschap; Hanneke W M van Laarhoven; Wim J G Oyen
Vascular and metabolic response to bevacizumab-containing regimens in two patients with colorectal liver metastases measured by dynamic contrast-enhanced MRI and dynamic 18F-FDG-PET.
Clinical colorectal cancer 2011;10(1):E1-5.
2011: G de Jong; Thijs Hendriks; G Franssen; Wim J G Oyen; Otto Boerman; Robert P Bleichrodt
Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2011;37(3):258-64.
2011: Rick C Helmich; Marcel J R Janssen; Wim J G Oyen; Bastiaan R Bloem; Ivan Toni
Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor.
Annals of neurology 2011;69(2):269-81.
2011: Gabie M de Jong; Thijs Hendriks; Annemarie Eek; Wim J G Oyen; Iris Nagtegaal; Robert P Bleichrodt; Otto C Boerman
Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases.
Annals of surgery 2011;253(2):336-41.
2011: Ingrid Dijkgraaf; Cheng-Bin Yim; Gerben M Franssen; Robert Schuit; Gert Luurtsema; Shuang Liu; Wim J G Oyen; Otto C Boerman
PET imaging of αvβ₃ integrin expression in tumours with ⁶⁸Ga-labelled mono-, di- and tetrameric RGD peptides.
European journal of nuclear medicine and molecular imaging 2011;38(1):128-37.
2010: Martin Gotthardt; Chantal P Bleeker-Rovers; Otto C Boerman; Wim J G Oyen
Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(12):1937-49.
2010: Rafke Schoffelen; Winette T A van der Graaf; Gerben Franssen; Robert M Sharkey; David M Goldenberg; William J McBride; Edmund A Rossi; Annemarie Eek; Wim J G Oyen; Otto C Boerman
Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(11):1780-7.
2010: Ingrid M E Desar; Alexander B Stillebroer; Egbert Oosterwijk; William P J Leenders; Carla M L van Herpen; Winette T A van der Graaf; Otto C Boerman; Peter F A Mulders; Wim J G Oyen
111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(11):1707-15.
2010: Bastiaan Wiering; Eddy M M Adang; Joost R M van der Sijp; Rudi M Roumen; Koert P de Jong; Emile F I Comans; Jan Pruim; Helena M Dekker; T J M Ruers; Paul Krabbe; Wim J G Oyen
Added value of positron emission tomography imaging in the surgical treatment of colorectal liver metastases.
Nuclear medicine communications 2010;31(11):938-44.
2010: Bernadette G Dijkman; Olga C J Schuurbiers; Dennis Vriens; Monika Looijen-Salamon; Johan Bussink; Johanna N H Timmer-Bonte; Miranda M Snoeren; Wim J G Oyen; Henricus F M van der Heijden; Lioe-Fee de Geus-Oei
The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.
European journal of nuclear medicine and molecular imaging 2010;37(11):2037-47.
2010: Sandra Heskamp; Hanneke W M van Laarhoven; Janneke D M Molkenboer-Kuenen; Gerben M Franssen; Yvonne M H Versleijen-Jonkers; Wim J G Oyen; Winette T A van der Graaf; Otto C Boerman
ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(10):1565-72.
2010: Martin Gotthardt; Anne Arens; Erik van der Heijden; Lioe-Fee de Geus-Oei; Wim J G Oyen
Nodular fasciitis on F-18 FDG PET.
Clinical nuclear medicine 2010;35(10):830-1.
2010: Esther G C Troost; Dominic A X Schinagl; Johan Bussink; Wim J G Oyen; Johannes H A M Kaanders
Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;96(3):328-34.
2010: M Srinivas; E H J G Aarntzen; Jeff W M Bulte; Wim J G Oyen; Arend Heerschap; I Jolanda M De Vries; Carl Figdor
Imaging of cellular therapies.
Advanced drug delivery reviews 2010;62(11):1080-93.
2010: Fidel J Vos; Chantal P Bleeker-Rovers; P D J Sturm; Paul Krabbe; Arie P J van Dijk; Maria L H Cuijpers; Eddy M M Adang; Geert J A Wanten; Bart Jan Kullberg; Wim J G Oyen
18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(8):1234-40.
2010: Erik Vegt; Marion De Jong; Jack F M Wetzels; Rosalinde Masereeuw; Marleen Melis; Wim J G Oyen; Martin Gotthardt; Otto Boerman
Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(7):1049-58.
2010: Bianca A W Hoeben; Johannes H A M Kaanders; Gerben M Franssen; Esther G C Troost; Paul F J W Rijken; Egbert Oosterwijk; Guus A M S van Dongen; Wim J G Oyen; Otto Boerman; Johan Bussink
PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(7):1076-83.
2010: Alexander B Stillebroer; Peter F A Mulders; Otto C Boerman; Wim J G Oyen; Egbert Oosterwijk
Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
European urology 2010;58(1):75-83.
2010: Johan Bussink; Carla M L van Herpen; Johannes H A M Kaanders; Wim J G Oyen
PET-CT for response assessment and treatment adaptation in head and neck cancer.
The lancet oncology 2010;11(7):661-9.
2010: Maarten Brom; Wim J G Oyen; Lieke Joosten; Martin Gotthardt; Otto Boerman
68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.
European journal of nuclear medicine and molecular imaging 2010;37(7):1345-55.
2010: Dennis Vriens; Eric P Visser; Lioe-Fee de Geus-Oei; Wim J G Oyen
Methodological considerations in quantification of oncological FDG PET studies.
European journal of nuclear medicine and molecular imaging 2010;37(7):1408-25.
2010: Esther G C Troost; Johan Bussink; Aswin L Hoffmann; Otto Boerman; Wim J G Oyen; Johannes H A M Kaanders
18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(6):866-74.
2010: Rozemarie Gilles; Wouter V Vogel; Corrie E M Gidding; Geert O R J Janssens; Ton M van der Vliet; Wim J G Oyen
(18)F-fluoro-L-thymidine-PET for the evaluation of primary brain tumours in children: a report of three cases.
Nuclear medicine communications 2010;31(6):482-7.
2010: Esther G C Troost; Johan Bussink; Pieter J Slootweg; Wenny J M Peeters; M A W Merkx; Albert J van der Kogel; Wim J G Oyen; Johannes H A M Kaanders
Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(5):713-9.
2010: Maarten Brom; Karolina Andrałojć; Wim J G Oyen; Otto Boerman; Martin Gotthardt
Development of radiotracers for the determination of the beta-cell mass in vivo.
Current pharmaceutical design 2010;16(14):1561-7.
2010: Niels B Kock; Esther van Tankeren; Wim J G Oyen; Ate B Wymenga; Job L C van Susante
Bone scintigraphy after osteochondral autograft transplantation in the knee: 13 patients followed for 4 years.
Acta orthopaedica 2010;81(2):206-10.
2010: Rafke Schoffelen; Robert M Sharkey; David M Goldenberg; Gerben Franssen; William J McBride; Edmund A Rossi; Chien-Hsing Chang; Peter Laverman; Jonathan A Disselhorst; Annemarie Eek; Winette T A van der Graaf; Wim J G Oyen; Otto Boerman
Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.
Molecular cancer therapeutics 2010;9(4):1019-27.
2010: Jonathan A Disselhorst; Maarten Brom; Peter Laverman; Cornelius H Slump; Otto Boerman; Wim J G Oyen; Martin Gotthardt; Eric P Visser
Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(4):610-7.
2010: Esther G C Troost; Dominic A X Schinagl; Johan Bussink; Johannes H A M Kaanders; Wim J G Oyen; Otto Boerman
Correlation of segmented metabolic tumor volume with outcome--letter.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(6):1968; author reply 1968-9.
2010: Peter Laverman; William J McBride; Robert M Sharkey; Annemarie Eek; Lieke Joosten; Wim J G Oyen; David M Goldenberg; Otto Boerman
A novel facile method of labeling octreotide with (18)F-fluorine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(3):454-61.
2010: Koen S Simons; Peter Pickkers; Chantal P Bleeker-Rovers; Wim J G Oyen; Johannes G van der Hoeven
F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection.
Intensive care medicine 2010;36(3):504-11.
2010: Frits Aarts; Otto Boerman; Robert M Sharkey; Thijs Hendriks; Chien-Hsing Chang; William J McBride; Robert P Bleichrodt; Wim J G Oyen; David M Goldenberg
Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody.
Cancer 2010;116(4 Suppl):1111-7.
2010: Eric P Visser; Otto Boerman; Wim J G Oyen
SUV: from silly useless value to smart uptake value.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(2):173-5.
2010: Erik Vegt; Annemarie Eek; Wim J G Oyen; Marion De Jong; Martin Gotthardt; Otto Boerman
Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.
European journal of nuclear medicine and molecular imaging 2010;37(2):226-34.
2010: Esther G C Troost; Dominic A X Schinagl; Johan Bussink; Otto Boerman; Albert J van der Kogel; Wim J G Oyen; Johannes H A M Kaanders
Innovations in radiotherapy planning of head and neck cancers: role of PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(1):66-76.
2010: Wouter van der Bruggen; Chantal P Bleeker-Rovers; Otto Boerman; Martin Gotthardt; Wim J G Oyen
PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review.
Seminars in nuclear medicine 2010;40(1):3-15.
2010: Ronald Boellaard; Mike J O'Doherty; Wolfgang A Weber; Felix M Mottaghy; Markus N Lonsdale; Sigrid Stroobants; Wim J G Oyen; Joerg Kotzerke; Otto S Hoekstra; Jan Pruim; Paul K Marsden; Klaus Tatsch; Corneline Hoekstra; Eric P Visser; Bertjan Arends; Fred J Verzijlbergen; Josee M Zijlstra; Emile F I Comans; Adriaan A Lammertsma; Anne M J Paans; Antoon T Willemsen; Thomas Beyer; Andreas Bockisch; Cornelia Schaefer-Prokop; Dominique Delbeke; Richard P Baum; Arturo Chiti; Bernd J Krause
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.
European journal of nuclear medicine and molecular imaging 2010;37(1):181-200.
2009: Dennis Vriens; Lioe-Fee de Geus-Oei; Wim J G Oyen; Eric P Visser
A curve-fitting approach to estimate the arterial plasma input function for the assessment of glucose metabolic rate and response to treatment.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(12):1933-9.
2009: Susanne Lütje; Jacky W J de Rooy; Sandra Croockewit; Emmeline Koedam; Wim J G Oyen; Reinier A P Raymakers
Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma.
Annals of hematology 2009;88(12):1161-8.
2009: Annelies Draisma; Moniek de Goeij; Constantijn W Wouters; Niels P Riksen; Wim J G Oyen; Gerard A Rongen; Otto Boerman; Marcel van Deuren; Johannes G van der Hoeven; Peter Pickkers
Endotoxin tolerance does not limit mild ischemia-reperfusion injury in humans in vivo.
Innate immunity 2009;15(6):360-7.
2009: Dennis Vriens; Hanneke W M van Laarhoven; Jack J A van Asten; Paul Krabbe; Eric P Visser; Arend Heerschap; Cornelis J A Punt; Lioe-Fee de Geus-Oei; Wim J G Oyen
Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(11):1777-84.
2009: Henriette A C Kyrieleis; MM Löwik; Ilse Pronk; Hans R M Cruysberg; Jan A M Kremer; Wim J G Oyen; Bert L P van den Heuvel; Jack F M Wetzels; Elena N Levtchenko
Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(10):1593-600.
2009: Wim J G Oyen; Winette T A van der Graaf
Molecular imaging of solid tumors: exploiting the potential.
Nature reviews. Clinical oncology 2009;6(10):609-11.
2009: Esther Bastiaannet; Theo Wobbes; Otto S Hoekstra; Eric J van der Jagt; Adrienne H Brouwers; Ron Koelemij; John M H de Klerk; Wim J G Oyen; Sybren Meijer; Harald J Hoekstra
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4774-80.
2009: Peter Laverman; Silvie A Meeuwissen; Sander S van Berkel; Wim J G Oyen; Floris L van Delft; Floris P J T Rutjes; Otto Boerman
In-depth evaluation of the cycloaddition--retro-Diels--Alder reaction for in vivo targeting with [(111)In]-DTPA-RGD conjugates.
Nuclear medicine and biology 2009;36(7):749-57.
2009: T J M Ruers; Bastiaan Wiering; Joost R M van der Sijp; Rudi M Roumen; Koert P de Jong; Emile F I Comans; Jan Pruim; Heleen M Dekker; Paul Krabbe; Wim J G Oyen
Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(7):1036-41.
2009: Carla M L van Herpen; Winette T A van der Graaf; Wim J G Oyen
Time to target evaluation criteria of targeted therapies.
Nuclear medicine communications 2009;30(7):487-9.
2009: Gabie M de Jong; Thijs Hendriks; Annemarie Eek; Wim J G Oyen; Sandra Heskamp; Robert P Bleichrodt; Otto Boerman
Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin.
Annals of surgical oncology 2009;16(7):2065-73.
2009: Dennis Vriens; Lioe-Fee de Geus-Oei; Hanneke W M van Laarhoven; Johanna N H Timmer-Bonte; Paul Krabbe; Eric P Visser; Wim J G Oyen
Evaluation of different normalization procedures for the calculation of the standardized uptake value in therapy response monitoring studies.
Nuclear medicine communications 2009;30(7):550-7.
2009: Cornelis J J M Sikkink; Michel M P J Reijnen; Peter Laverman; Wim J G Oyen; Harry van Goor
Tc-99m-PEG-liposomes target both adhesions and abscesses and their reduction by hyaluronate in rats with fecal peritonitis.
The Journal of surgical research 2009;154(2):246-51.
2009: Olga C J Schuurbiers; Johannes H A M Kaanders; Henricus F M van der Heijden; Richard P N Dekhuijzen; Wim J G Oyen; Johan Bussink
The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(6):761-7.
2009: Patrick Meijer; Wim J G Oyen; Douwe Dekker; Petra H H van den Broek; Constatijn W Wouters; Otto Boerman; Gert Jan Scheffer; Paul Smits; Gerard A Rongen
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(6):963-8.
2009: Lioe-Fee de Geus-Oei; Dennis Vriens; Hanneke W M van Laarhoven; Winette T A van der Graaf; Wim J G Oyen
Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50 Suppl 1():43S-54S.
2009: Thamar H Stollman; scheer med; Gerben M Franssen; Kiek N Verrijp; Wim J G Oyen; Theo J M Ruers; William P J Leenders; Otto Boerman
Tumor accumulation of radiolabeled bevacizumab due to targeting of cell- and matrix-associated VEGF-A isoforms.
Cancer biotherapy & radiopharmaceuticals 2009;24(2):195-200.
2009: Danita Schuurhuis; Pauline Verdijk; Gerty Schreibelt; Erik H J G Aarntzen; Nicole M Scharenborg; Annemiek de Boer; Mandy W M M van de Rakt; Marieke Kerkhoff; Marie-Jeanne P Gerritsen; Femke Eijckeler; Johannes J Bonenkamp; Willeke Blokx; J Han van Krieken; Otto Boerman; Wim J G Oyen; Cornelis J A Punt; Carl G Figdor; Gosse J Adema; I Jolanda M De Vries
In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients.
Cancer research 2009;69(7):2927-34.
2009: Pauline Verdijk; Erik H J G Aarntzen; W Joost Lesterhuis; A C Inge Boullart; Ellemieke Kok; Michelle M van Rossum; Simon Strijk; Femke Eijckeler; Johannes J Bonenkamp; Joannes F M Jacobs; Willeke Blokx; J Han J M Vankrieken; Irma Joosten; Otto Boerman; Wim J G Oyen; Gosse J Adema; Cornelis J A Punt; Carl G Figdor; I Jolanda M De Vries
Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(7):2531-40.
2009: Dominic A X Schinagl; Aswin L Hoffmann; Wouter V Vogel; Jorn A van Dalen; Suzan M M Verstappen; Wim J G Oyen; Johannes H A M Kaanders
Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;91(1):95-100.
2009: Ineke Krabbendam; Martje L Maas; Dick H J Thijssen; Wim J G Oyen; Fred K Lotgering; Maria T E Hopman; Marc E A Spaanderman
Exercise-induced changes in venous vascular function in nonpregnant formerly preeclamptic women.
Reproductive sciences (Thousand Oaks, Calif.) 2009;16(4):414-20.
2009: Esther G C Troost; Johan Bussink; Wim J G Oyen; Johannes H A M Kaanders
18F-FDG and 18F-FLT do not discriminate between reactive and metastatic lymph nodes in oral cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(3):490-1.
2009: Chantal P Bleeker-Rovers; Jos W M van der Meer; Wim J G Oyen
Fever of unknown origin.
Seminars in nuclear medicine 2009;39(2):81-7.
2009: Hanneke W M van Laarhoven; Maarten Vinken; Roel Mus; Uta Flucke; Wim J G Oyen; Winette T Van der Graaf
The diagnostic hurdle of an elderly male with bone pain: how 18F-FDG-PET led to diagnosis of a leiomyosarcoma of the adrenal gland.
Anticancer research 2009;29(2):469-72.
2009: Frits Aarts; Thijs Hendriks; Annemarie Eek; Wim J G Oyen; Robert P Bleichrodt; Otto Boerman
Can antibody galactosylation be used to improve radioimmunotherapy of induced peritoneal carcinomatosis of colonic origin in the rat?
Cancer biotherapy & radiopharmaceuticals 2009;24(1):29-34.
2009: Eric P Visser; Jonathan A Disselhorst; Maarten Brom; Peter Laverman; Martin Gotthardt; Wim J G Oyen; Otto Boerman
Spatial resolution and sensitivity of the Inveon small-animal PET scanner.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(1):139-47.
2008: Esther G C Troost; Peter Laverman; Johannes H A M Kaanders; Wim J G Oyen; Otto Boerman; Johan Bussink
Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-gluco-RGD autoradiography.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(10):1732; author reply 1732-3.
2008: Esther G C Troost; Peter Laverman; Mariëlle E P Philippens; Jasper Lok; Albert J van der Kogel; Wim J G Oyen; Otto Boerman; Johannes H A M Kaanders; Johan Bussink
Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts.
European journal of nuclear medicine and molecular imaging 2008;35(10):1803-11.
2008: Erik Vegt; Julliëtte E M van Eerd; Annemarie Eek; Wim J G Oyen; Jack F M Wetzels; Marion De Jong; Frans G M Russel; Rosalinde Masereeuw; Martin Gotthardt; Otto Boerman
Reducing renal uptake of radiolabeled peptides using albumin fragments.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(9):1506-11.
2008: Marian G W Scheer; Thamar H Stollman; Otto Boerman; Kiek Verrijp; Fred C G J Sweep; William P J Leenders; T J M Ruers; Wim J G Oyen
Imaging liver metastases of colorectal cancer patients with radiolabelled bevacizumab: Lack of correlation with VEGF-A expression.
European journal of cancer (Oxford, England : 1990) 2008;44(13):1835-40.
2008: Maarten Truijers; Harrie A J M Kurvers; Sebastian J H Bredie; Wim J G Oyen; Jan D Blankensteijn
In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2008;15(4):462-7.
2008: Adrienne H Brouwers; Peter F A Mulders; Wim J G Oyen
Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3808-9; author reply 3811-2.
2008: Otto Boerman; Wim J G Oyen
Multimodality probes: amphibian cars for molecular imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(8):1213-4.
2008: Ineke Krabbendam; Ben J Janssen; Arie P J van Dijk; Henk Jongsma; Wim J G Oyen; Fred K Lotgering; Marc E A Spaanderman
The relation between venous reserve capacity and low plasma volume.
Reproductive sciences (Thousand Oaks, Calif.) 2008;15(6):604-12.
2008: Marc D Zuijdwijk; Wouter V Vogel; Frans H M Corstens; Wim J G Oyen
Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma.
Nuclear medicine communications 2008;29(7):636-41.
2008: Frits Aarts; Thijs Hendriks; Otto Boerman; Wim J G Oyen; Robert P Bleichrodt
Hyperthermia and fibrinolytic therapy do not improve the beneficial effect of radioimmunotherapy following cytoreductive surgery in rats with peritoneal carcinomatosis of colorectal origin.
Cancer biotherapy & radiopharmaceuticals 2008;23(3):301-9.
2008: Eric P Visser; Mariëlle E P Philippens; Laura Kienhorst; Johannes H A M Kaanders; Frans H M Corstens; Lioe-Fee de Geus-Oei; Wim J G Oyen
Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(6):892-8.
2008: Marian G W Scheer; Thamar H Stollman; Wouter V Vogel; Otto Boerman; Wim J G Oyen; T J M Ruers
Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(6):887-91.
2008: Thamar H Stollman; Marian G W Scheer; William P J Leenders; Kiek Verrijp; Annemieke C Soede; Wim J G Oyen; T J M Ruers; Otto Boerman
Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody.
International journal of cancer. Journal international du cancer 2008;122(10):2310-4.
2008: Asaf Senft; Remco de Bree; Otto S Hoekstra; Dirk J Kuik; Richard P Golding; Wim J G Oyen; Jan Pruim; Frank J A van den Hoogen; Jan L N Roodenburg; René Leemans
Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;87(2):221-9.
2008: Frits Aarts; Robert P Bleichrodt; Wim J G Oyen; Otto Boerman
Intracavitary radioimmunotherapy to treat solid tumors.
Cancer biotherapy & radiopharmaceuticals 2008;23(1):92-107.
2008: Peter Laverman; Susan Roosenburg; Martin Gotthardt; Jeseong Park; Wim J G Oyen; Marion De Jong; Mark R Hellmich; Floris P J T Rutjes; Floris L van Delft; Otto Boerman
Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.
European journal of nuclear medicine and molecular imaging 2008;35(2):386-92.
2008: Bastiaan Wiering; Wouter V Vogel; T J M Ruers; Wim J G Oyen
Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Digestive surgery 2008;25(6):413-20.
2008: Lioe-Fee de Geus-Oei; Wim J G Oyen
Predictive and prognostic value of FDG-PET.
Cancer imaging : the official publication of the International Cancer Imaging Society 2008;8():70-80.
2007: Dominic A X Schinagl; Wouter V Vogel; Aswin L Hoffmann; Jorn A van Dalen; Wim J G Oyen; Johannes H A M Kaanders
Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
International journal of radiation oncology, biology, physics 2007;69(4):1282-9.
2007: Wouter K de Jong; Henricus F M van der Heijden; Jan Pruim; Otilia Dalesio; Wim J G Oyen; Harry J M Groen
Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(11):1007-12.
2007: Frits Aarts; Thijs Hendriks; Otto Boerman; Manuel J Koppe; Wim J G Oyen; Robert P Bleichrodt
A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Annals of surgical oncology 2007;14(11):3274-82.
2007: Daan B de Koning; Joost P H Drenth; Wim J G Oyen; Michiel Wagenaar; Riena P Aliredjo; Fokko M Nagengast
Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: report of a case.
Diseases of the colon and rectum 2007;50(11):1987-91.
2007: Wim J G Oyen; Lisa Bodei; Francesco Giammarile; Helmut R Maecke; Jan Tennvall; M Luster; Boudewijn Brans
Targeted therapy in nuclear medicine--current status and future prospects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(11):1782-92.
2007: Lioe-Fee de Geus-Oei; Henricus F M van der Heijden; Frans H M Corstens; Wim J G Oyen
Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.
Cancer 2007;110(8):1654-64.
2007: J A Ropela; L van Die; Wim J G Oyen; Gerard A Rongen
Fever and cough in a patient with diabetes. Empyema caused by S. typhimurium.
The Netherlands journal of medicine 2007;65(9):357, 358.
2007: Lioe-Fee de Geus-Oei; Henricus F M van der Heijden; Eric P Visser; Rick Hermsen; Bas A van Hoorn; Johanna N H Timmer-Bonte; Antoon T Willemsen; Jan Pruim; Frans H M Corstens; Paul Krabbe; Wim J G Oyen
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(10):1592-8.
2007: Ingrid Dijkgraaf; Otto Boerman; Wim J G Oyen; Frans H M Corstens; Martin Gotthardt
Development and application of peptide-based radiopharmaceuticals.
Anti-cancer agents in medicinal chemistry 2007;7(5):543-51.
2007: A L M Oei; L F A G Massuger; Wim J G Oyen
Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancer.
Cancer biotherapy & radiopharmaceuticals 2007;22(4):508-14.
2007: Huub J J M Rennen; Peter Laverman; Julliëtte E M van Eerd; Wim J G Oyen; Frans H M Corstens; Otto Boerman
PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation.
Nuclear medicine and biology 2007;34(6):691-5.
2007: Charlotte A Haaxma; Bastiaan R Bloem; George F Borm; Wim J G Oyen; Klaus L Leenders; Silvia Eshuis; Jan Booij; Dean E Dluzen; Martin Horstink
Gender differences in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2007;78(8):819-24.
2007: Wouter V Vogel; Jorn A van Dalen; Bastiaan Wiering; Henkjan J Huisman; Frans H M Corstens; T J M Ruers; Wim J G Oyen
Evaluation of image registration in PET/CT of the liver and recommendations for optimized imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(6):910-9.
2007: Jorn A van Dalen; Aswin L Hoffmann; Volker Dicken; Wouter V Vogel; Bastiaan Wiering; T J M Ruers; Nico Karssemeijer; Wim J G Oyen
A novel iterative method for lesion delineation and volumetric quantification with FDG PET.
Nuclear medicine communications 2007;28(6):485-93.
2007: Otto Boerman; Manuel J Koppe; Ernst J Postema; Frans H M Corstens; Wim J G Oyen
Radionuclide therapy of cancer with radiolabeled antibodies.
Anti-cancer agents in medicinal chemistry 2007;7(3):335-43.
2007: Esther G C Troost; Wouter V Vogel; M A W Merkx; Pieter J Slootweg; Henri Marres; Wenny J M Peeters; Johan Bussink; Albert J van der Kogel; Wim J G Oyen; Johannes H A M Kaanders
18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(5):726-35.
2007: Niels P Riksen; Barbara Franke; Wim J G Oyen; George F Borm; Petra van den Broek; Otto Boerman; Paul Smits; Gerard A Rongen
Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene.
European heart journal 2007;28(9):1085-91.
2007: Boudewijn Brans; Lisa Bodei; Francesco Giammarile; O Linden; M Luster; Wim J G Oyen; Jan Tennvall
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".
European journal of nuclear medicine and molecular imaging 2007;34(5):772-86.
2007: Chantal P Bleeker-Rovers; Fidel J Vos; Aart H Mudde; Anton S M Dofferhoff; Lioe-Fee de Geus-Oei; Anton J Rijnders; Paul Krabbe; Frans H M Corstens; Jos W M van der Meer; Wim J G Oyen
A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin.
European journal of nuclear medicine and molecular imaging 2007;34(5):694-703.
2007: A W van der Eerden; Martin den Heijer; Wim J G Oyen; Ad R M M Hermus
Cushing's syndrome and bone mineral density: lowest Z scores in young patients.
The Netherlands journal of medicine 2007;65(4):137-41.
2007: Martin Gotthardt; Julliëtte van Eerd-Vismale; Wim J G Oyen; Marion De Jong; Hanwen Zhang; Edgar J Rolleman; Helmut R Maecke; Martin Béhé; Otto Boerman
Indication for different mechanisms of kidney uptake of radiolabeled peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):596-601.
2007: Aswin L Hoffmann; Jorn A van Dalen; John Lee; Vincent Grégoire; Wim J G Oyen; Johannes H A M Kaanders
Regarding Davis et al.: Assessment of (18)F PET signals for automatic target volume definition in radiotherapy treatment planning.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(1):102-3; author reply 103.
2007: Hans J C Berger; Sieberen van der Werf; Casper A Horstink; Alexander R Cools; Wim J G Oyen; Martin Horstink
Writer's cramp: restoration of striatal D2-binding after successful biofeedback-based sensorimotor training.
Parkinsonism & related disorders 2007;13(3):170-3.
2007: C C P Verstappen; Bastiaan R Bloem; Charlotte A Haaxma; Wim J G Oyen; Martin Horstink
Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study.
European journal of nuclear medicine and molecular imaging 2007;34(4):502-7.
2007: Jorn A van Dalen; Eric P Visser; Wouter V Vogel; Frans H M Corstens; Wim J G Oyen
Impact of Ge-68/Ga-68-based versus CT-based attenuation correction on PET.
Medical physics 2007;34(3):889-97.
2007: Chantal P Bleeker-Rovers; Huub J J M Rennen; Otto Boerman; Ate B Wymenga; Eric P Visser; Johannes H Bakker; Jos W M van der Meer; Frans H M Corstens; Wim J G Oyen
99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(3):337-43.
2007: T J M Ruers; Joris J Joosten; Bastiaan Wiering; Barbara S Langenhoff; Heleen M Dekker; Theo Wobbes; Wim J G Oyen; Paul Krabbe; Cornelis J A Punt
Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.
Annals of surgical oncology 2007;14(3):1161-9.
2007: Eric P Visser; Ernst J Postema; Otto Boerman; Jeroen Visschers; Wim J G Oyen; Frans H M Corstens
Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND).
European journal of nuclear medicine and molecular imaging 2007;34(3):413-21.
2007: Wouter V Vogel; P L C M van Riel; Wim J G Oyen
FDG-PET/CT can visualise the extent of inflammation in rheumatoid arthritis of the tarsus.
European journal of nuclear medicine and molecular imaging 2007;34(3):439.
2007: Marinke Westerterp; Jan Pruim; Wim J G Oyen; Otto S Hoekstra; Anne M J Paans; Eric P Visser; Jan van Lanschot; Gerrit W Sloof; Ronald Boellaard
Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.
European journal of nuclear medicine and molecular imaging 2007;34(3):392-404.
2007: Peter Laverman; Willeke A M Blokx; René H M Te Morsche; Cathelijne Frielink; Otto Boerman; Wim J G Oyen; Joost P H Drenth
[(18)F]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma.
Hepatology research : the official journal of the Japan Society of Hepatology 2007;37(2):127-32.
2007: M L H Cuijpers; Fidel J Vos; Chantal P Bleeker-Rovers; Paul Krabbe; Peter Pickkers; A P J van Dijk; Geert J A Wanten; P D J Sturm; Wim J G Oyen; Bart Jan Kullberg
Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(2):105-13.
2007: Bastiaan Wiering; T J M Ruers; Paul Krabbe; Heleen M Dekker; Wim J G Oyen
Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.
Annals of surgical oncology 2007;14(2):818-26.
2007: Frits Aarts; Manuel J Koppe; Thijs Hendriks; Julliëtte E M van Eerd; Wim J G Oyen; Otto Boerman; Robert P Bleichrodt
Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin.
Annals of surgical oncology 2007;14(2):533-40.
2007: Ingrid Dijkgraaf; John A W Kruijtzer; Cathelijne Frielink; Frans H M Corstens; Wim J G Oyen; Rob M J Liskamp; Otto Boerman
Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.
International journal of cancer. Journal international du cancer 2007;120(3):605-10.
2007: Bastiaan Wiering; Paul Krabbe; Heleen M Dekker; Wim J G Oyen; T J M Ruers
The role of FDG-PET in the selection of patients with colorectal liver metastases.
Annals of surgical oncology 2007;14(2):771-9.
2007: Ingrid Dijkgraaf; John A W Kruijtzer; Shuang Liu; Annemieke C Soede; Wim J G Oyen; Frans H M Corstens; Rob M J Liskamp; Otto Boerman
Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.
European journal of nuclear medicine and molecular imaging 2007;34(2):267-73.
2007: Alexander B Stillebroer; Egbert Oosterwijk; Wim J G Oyen; Peter F A Mulders; Otto Boerman
Radiolabeled antibodies in renal cell carcinoma.
Cancer imaging : the official publication of the International Cancer Imaging Society 2007;7():179-88.
2007: Jorn A van Dalen; Wouter V Vogel; Frans H M Corstens; Wim J G Oyen
Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations.
Cancer imaging : the official publication of the International Cancer Imaging Society 2007;7():77-83.
2007: Jón O Kristinsson; Wim P M Hopman; Wim J G Oyen; Joost P H Drenth
Gastroparesis in patients with inactive Crohn's disease: a case series.
BMC gastroenterology 2007;7():11.
2007: Chantal P Bleeker-Rovers; Fidel J Vos; Elisabeth M H A de Kleijn; Aart H Mudde; Ton S M Dofferhoff; Clemens Richter; Tineke J Smilde; Paul Krabbe; Wim J G Oyen; Jos W M van der Meer
A prospective multicenter study on fever of unknown origin: the yield of a structured diagnostic protocol.
Medicine 2007;86(1):26-38.
2007: Ingrid Dijkgraaf; Shuang Liu; John A W Kruijtzer; Annemieke C Soede; Wim J G Oyen; Rob M J Liskamp; Frans H M Corstens; Otto Boerman
Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.
Nuclear medicine and biology 2007;34(1):29-35.
2007: Lioe-Fee de Geus-Oei; J H J M van Krieken; Riena P Aliredjo; Paul Krabbe; Cathelijne Frielink; Ad F T M Verhagen; Otto Boerman; Wim J G Oyen
Biological correlates of FDG uptake in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2007;55(1):79-87.
2006: Martin Gotthardt; Martin Béhé; Julia Grass; Artur Bauhofer; Anja Rinke; Meike L Schipper; Marc Kalinowski; Rudolf Arnold; Wim J G Oyen; Thomas M Behr
Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours.
Endocrine-related cancer 2006;13(4):1203-11.
2006: Ingrid Dijkgraaf; John A W Kruijtzer; Cathelijne Frielink; Annemieke C Soede; Hans W Hilbers; Wim J G Oyen; Frans H M Corstens; Rob M J Liskamp; Otto Boerman
Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.
Nuclear medicine and biology 2006;33(8):953-61.
2006: Manuel J Koppe; Thijs Hendriks; Otto Boerman; Wim J G Oyen; Robert P Bleichrodt
Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(11):1867-74.
2006: Lioe-Fee de Geus-Oei; Bastiaan Wiering; Paul Krabbe; T J M Ruers; Cornelis J A Punt; Wim J G Oyen
FDG-PET for prediction of survival of patients with metastatic colorectal carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1650-5.
2006: Julliëtte E M van Eerd; Lioe-Fee de Geus-Oei; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Scintigraphic imaging of P-glycoprotein expression with a radiolabelled antibody.
European journal of nuclear medicine and molecular imaging 2006;33(11):1266-72.
2006: Martin Gotthardt; Martin Béhé; Daniela Beuter; Anke Battmann; Artur Bauhofer; Tino Schurrat; Meike L Schipper; Halina Pollum; Wim J G Oyen; Thomas M Behr
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.
European journal of nuclear medicine and molecular imaging 2006;33(11):1273-9.
2006: Manuel J Koppe; Wim J G Oyen; Robert P Bleichrodt; Albert A J Verhofstad; David M Goldenberg; Otto Boerman
Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
Cancer biotherapy & radiopharmaceuticals 2006;21(5):506-14.
2006: Fidel J Vos; Chantal P Bleeker-Rovers; A P J van Dijk; Wim J G Oyen
Detection of pacemaker and lead infection with FDG-PET.
European journal of nuclear medicine and molecular imaging 2006;33(10):1245.
2006: Wouter V Vogel; Jorn A van Dalen; Wim J G Oyen
Adequate evaluation of image registration in hybrid PET/CT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(9):1556; author reply 1557-8.
2006: Niels P Riksen; Zhigang Zhou; Wim J G Oyen; Rogier Jaspers; Bart P Ramakers; Rene M H J Brouwer; Otto Boerman; Neil Steinmetz; Paul Smits; Gerard A Rongen
Caffeine prevents protection in two human models of ischemic preconditioning.
Journal of the American College of Cardiology 2006;48(4):700-7.
2006: Esther G C Troost; Peter Laverman; Johannes H A M Kaanders; Mariëlle E P Philippens; Jasper Lok; Wim J G Oyen; Albert J van der Kogel; Otto Boerman; Johan Bussink
Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):157-64.
2006: Dirk M Scharn; Wim J G Oyen; Peter L Klemm; Albert A J Verhofstad; J Adam van der Vliet
Thrombogenicity and related biological properties of heparin bonded collagen coated polyester and human umbilical vein prosthetic vascular grafts.
The Journal of surgical research 2006;134(2):182-9.
2006: Jelle O Barentsz; satoru takahashi; Wim J G Oyen; Roel Mus; P H M De Mulder; Rodney H Reznek; Matthijs Oudkerk; Wim Mali
Commonly used imaging techniques for diagnosis and staging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(20):3234-44.
2006: Lioe-Fee de Geus-Oei; Johannes H A M Kaanders; Lucas A M Pop; Frans H M Corstens; Wim J G Oyen
Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(1):51-6.
2006: Esther Bastiaannet; Otto S Hoekstra; Wim J G Oyen; Pieter L Jager; Theo Wobbes; Harald J Hoekstra
Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases.
Annals of surgical oncology 2006;13(7):919-26.
2006: Baudewijn W Hendrickx; Cees J A Punt; Otto Boerman; Ernst J Postema; Egbert Oosterwijk; Agapi Mavridu; Frans H M Corstens; Wim J G Oyen
Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250.
Cancer biotherapy & radiopharmaceuticals 2006;21(3):263-8.
2006: Fidel J Vos; Chantal P Bleeker-Rovers; Frans H M Corstens; Bart Jan Kullberg; Wim J G Oyen
FDG-PET for imaging of non-osseous infection and inflammation.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2006;50(2):121-30.
2006: Lioe-Fee de Geus-Oei; Eric P Visser; Paul Krabbe; Bas A van Hoorn; Emile B Koenders; Antoon T Willemsen; Jan Pruim; Frans H M Corstens; Wim J G Oyen
Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(6):945-9.
2006: Wouter V Vogel; Jorn A van Dalen; Dominic A X Schinagl; Johannes H A M Kaanders; Henkjan J Huisman; Frans H M Corstens; Wim J G Oyen
Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT.
Nuclear medicine communications 2006;27(6):515-9.
2006: Peter Laverman; I Jolanda M De Vries; Nicole M Scharenborg; Annemiek de Boer; Matthias Broekema; Wim J G Oyen; Carl G Figdor; Gosse J Adema; Otto Boerman
Development of 111In-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination.
Nuclear medicine and biology 2006;33(4):453-8.
2006: Bart M Wensing; Wouter V Vogel; Henri Marres; M A W Merkx; Ernst J Postema; Wim J G Oyen; Frank J A van den Hoogen
FDG-PET in the clinically negative neck in oral squamous cell carcinoma.
The Laryngoscope 2006;116(5):809-13.
2006: Lioe-Fee de Geus-Oei; G F F M Pieters; Johannes J Bonenkamp; Aart H Mudde; Chantal P Bleeker-Rovers; Frans H M Corstens; Wim J G Oyen
18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):770-5.
2006: Ellen M Van Cann; Wim J G Oyen; Ron Koole; P J W Stoelinga
Bone SPECT reduces the number of unnecessary mandibular resections in patients with squamous cell carcinoma.
Oral oncology 2006;42(4):409-14.
2006: Julliëtte E M van Eerd; Erik Vegt; Jack F M Wetzels; Frans G M Russel; Rosalinde Masereeuw; Frans H M Corstens; Wim J G Oyen; Otto Boerman
Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):528-33.
2006: Erik Vegt; Jack F M Wetzels; Frans G M Russel; Rosalinde Masereeuw; Otto Boerman; Julliëtte E M van Eerd; Frans H M Corstens; Wim J G Oyen
Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):432-6.
2006: Mariëtte C A Van Kouwen; Joost P H Drenth; J H J M van Krieken; Harry van Goor; Pieter Friederich; Wim J G Oyen; Fokko M Nagengast
Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management.
European journal of nuclear medicine and molecular imaging 2006;33(3):270-4.
2006: Mariëtte C A Van Kouwen; Peter Laverman; J H J M van Krieken; Wim J G Oyen; Fokko M Nagengast; Joost P H Drenth
Noninvasive monitoring of colonic carcinogenesis: feasibility of [(18)F]FDG-PET in the azoxymethane model.
Nuclear medicine and biology 2006;33(2):245-8.
2006: Manuel J Koppe; Otto Boerman; Wim J G Oyen; Robert P Bleichrodt
Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
Annals of surgery 2006;243(2):212-22.
2006: Esther Bastiaannet; Wim J G Oyen; S Meijer; O S Hoekstra; Theo Wobbes; Pieter L Jager; Harald J Hoekstra
Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients.
The British journal of surgery 2006;93(2):243-9.
2006: Lioe-Fee de Geus-Oei; T J M Ruers; Cornelis J A Punt; Jan Willem Leer; Frans H M Corstens; Wim J G Oyen
FDG-PET in colorectal cancer.
Cancer imaging : the official publication of the International Cancer Imaging Society 2006;6():S71-81.
2006: Martin Gotthardt; Ingrid Dijkgraaf; Otto Boerman; Wim J G Oyen
Nuclear medicine imaging and therapy of neuroendocrine tumours.
Cancer imaging : the official publication of the International Cancer Imaging Society 2006;6():S178-84.
2006: Dominic A X Schinagl; Johannes H A M Kaanders; Wim J G Oyen
From anatomical to biological target volumes: the role of PET in radiation treatment planning.
Cancer imaging : the official publication of the International Cancer Imaging Society 2006;6():S107-16.
2006: Martin Gotthardt; C Rubner; Artur Bauhofer; F Berce; Wim J G Oyen; J Goecke; Andreas Pfestroff; Anja Schlieck; Frans H M Corstens; Martin Béhé; Thomas M Behr
What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
Nuklearmedizin. Nuclear medicine 2006;45(5):206-12.
2006: Manuel J Koppe; Wim J G Oyen; Robert P Bleichrodt; Thijs Hendriks; Albert A J Verhofstad; David M Goldenberg; Otto Boerman
Combination therapy using the cyclooxygenase-2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin.
Cancer immunology, immunotherapy : CII 2006;55(1):47-55.
2005: Adrienne H Brouwers; Otto Boerman; Wim J G Oyen
In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8886; author reply 8886.
2005: Bastiaan Wiering; Paul Krabbe; Gerrit J Jager; Wim J G Oyen; T J M Ruers
The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Cancer 2005;104(12):2658-70.
2005: E C T H Tan; Wim J G Oyen; R Jan A Goris
Leukocytes in Complex Regional Pain Syndrome type I.
Inflammation 2005;29(4-6):182-6.
2005: Manuel J Koppe; Ernst J Postema; Frits Aarts; Wim J G Oyen; Robert P Bleichrodt; Otto Boerman
Antibody-guided radiation therapy of cancer.
Cancer metastasis reviews 2005;24(4):539-67.
2005: Chantal P Bleeker-Rovers; Fidel J Vos; Geert J A Wanten; Jos W M van der Meer; Frans H M Corstens; Bart Jan Kullberg; Wim J G Oyen
18F-FDG PET in detecting metastatic infectious disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2014-9.
2005: Baudewijn W Hendrickx; C M L van Herpen; Johannes J Bonenkamp; Johannes Bulten; Wim J G Oyen
Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer. CASE 1. Mediastinal sarcoidosis in a melanoma patient treated with interferon.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8906-7.
2005: Joris J Joosten; GJ Jager; Wim J G Oyen; Theo Wobbes; T J M Ruers
Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2005;31(10):1152-9.
2005: I Jolanda M De Vries; W Joost Lesterhuis; Jelle O Barentsz; Pauline Verdijk; J H J M van Krieken; Otto Boerman; Wim J G Oyen; Johannes J Bonenkamp; Jan B M Boezeman; Gosse J Adema; Jeff W M Bulte; Tom W J Scheenen; Cornelis J A Punt; Arend Heerschap; Carl G Figdor
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy.
Nature biotechnology 2005;23(11):1407-13.
2005: M L E A Landheer; M G Steffens; J H G Klinkenbijl; A H Westenberg; Wim J G Oyen
Value of fluorodeoxyglucose positron emission tomography in women with breast cancer.
The British journal of surgery 2005;92(11):1363-7.
2005: Wouter V Vogel; Bart M Wensing; Jorn A van Dalen; Paul Krabbe; Frank J A van den Hoogen; Wim J G Oyen
Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.
European journal of nuclear medicine and molecular imaging 2005;32(11):1276-82.
2005: Matthias Broekema; Julliëtte J E M van Eerd; Wim J G Oyen; Frans H M Corstens; Rob M J Liskamp; Otto Boerman; Thomas D Harris
Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.
Journal of medicinal chemistry 2005;48(20):6442-53.
2005: K Kösters; Chantal P Bleeker-Rovers; Reinout van Crevel; Wim J G Oyen; Andre J A M van der Ven
Aortitis diagnosed by F-18-fluorodeoxyglucose positron emission tomography in a patient with syphilis and HIV coinfection.
Infection 2005;33(5-6):387-9.
2005: Adrienne H Brouwers; Wilhelmina C A M Buijs; Peter F A Mulders; P H M De Mulder; Wim J M van den Broek; Carola Mala; Egbert Oosterwijk; Otto Boerman; Frans H M Corstens; Wim J G Oyen
Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7178s-7186s.
2005: Hanneke W M van Laarhoven; Lioe-Fee de Geus-Oei; Bastiaan Wiering; Jasper Lok; Mark Rijpkema; Johannes H A M Kaanders; Paul Krabbe; T J M Ruers; Cornelis J A Punt; Albert J van der Kogel; Wim J G Oyen; Arend Heerschap
Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
Radiology 2005;237(1):181-8.
2005: Adrienne H Brouwers; Peter F A Mulders; P H M De Mulder; Wim J M van den Broek; Wilhelmina C A M Buijs; Carola Mala; Frank B M Joosten; Egbert Oosterwijk; Otto Boerman; Frans H M Corstens; Wim J G Oyen
Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6540-8.
2005: Julliëtte E M van Eerd; Matthias Broekema; Thomas D Harris; D Scott Edwards; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Imaging of infection and inflammation with an improved 99mTc-labeled LTB4 antagonist.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(9):1546-51.
2005: Niels P Riksen; Wim J G Oyen; Bart P Ramakers; Petra H H van den Broek; Richard Engbersen; Otto Boerman; Paul Smits; Gerard A Rongen
Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans.
Clinical pharmacology and therapeutics 2005;78(1):52-9.
2005: Mariëtte C A Van Kouwen; Peter Laverman; J H J M van Krieken; Wim J G Oyen; J B M J Jansen; Joost P H Drenth
FDG-PET in the detection of early pancreatic cancer in a BOP hamster model.
Nuclear medicine and biology 2005;32(5):445-50.
2005: Peter J M Kok; Julliëtte E M van Eerd; Otto Boerman; Frans H M Corstens; Wim J G Oyen
Biodistribution and imaging of FDG in rats with LS174T carcinoma xenografts and focal Escherichia coli infection.
Cancer biotherapy & radiopharmaceuticals 2005;20(3):310-5.
2005: Mariëtte C A Van Kouwen; Fokko M Nagengast; J B M J Jansen; Wim J G Oyen; Joost P H Drenth
2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3713-7.
2005: Chantal P Bleeker-Rovers; Adilia Warris; Joost P H Drenth; Frans H M Corstens; Wim J G Oyen; Bart Jan Kullberg
Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(6):493-5.
2005: Julliëtte E M van Eerd; Wim J G Oyen; Thomas D Harris; Huub J J M Rennen; D Scott Edwards; Frans H M Corstens; Otto Boerman
Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(5):786-93.
2005: Mariëtte C A Van Kouwen; J B M J Jansen; Harry van Goor; Steve de Castro; Wim J G Oyen; Joost P H Drenth
FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis.
European journal of nuclear medicine and molecular imaging 2005;32(4):399-404.
2005: Frank G van Schaijk; Egbert Oosterwijk; Janneke D Molkenboer-Kuenen; Annemieke C Soede; Bill J McBride; David M Goldenberg; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(3):495-501.
2005: Manuel J Koppe; Robert P Bleichrodt; Wim J G Oyen; Otto Boerman
Radioimmunotherapy and colorectal cancer.
The British journal of surgery 2005;92(3):264-76.
2005: Wouter V Vogel; Jorn A van Dalen; Henkjan J Huisman; Wim J G Oyen; Nico Karssemeijer
Sliced alternating DICOM series: convenient visualisation of image fusion on PACS.
European journal of nuclear medicine and molecular imaging 2005;32(2):247-8.
2005: Charlotte F J M Peeters; Lioe-Fee de Geus; Johan R Westphal; Robert M W de Waal; Dirk J Ruiter; Theo Wobbes; Wim J G Oyen; T J M Ruers
Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases.
Surgery 2005;137(2):246-9.
2005: Wim J G Oyen; Frans H M Corstens; Otto Boerman
Discriminating infection from sterile inflammation: can radiolabelled antibiotics solve the problem?
European journal of nuclear medicine and molecular imaging 2005;32(2):151-2.
2005: Gerard A Rongen; Wim J G Oyen; Bart P Ramakers; Niels P Riksen; Otto Boerman; Neil Steinmetz; Paul Smits
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans.
Circulation 2005;111(2):173-8.
2005: Wouter V Vogel; Bastiaan Wiering; Frans H M Corstens; T J M Ruers; Wim J G Oyen
Colorectal cancer: the role of PET/CT in recurrence.
Cancer imaging : the official publication of the International Cancer Imaging Society 2005;5 Spec No A():S143-9.
2005: Michel de Groot; Antoi P W Meeuwis; Peter J M Kok; Frans H M Corstens; Wim J G Oyen
Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut.
European journal of nuclear medicine and molecular imaging 2005;32(1):98-101.
2004: Jorn A van Dalen; W Vogel; Henkjan J Huisman; Wim J G Oyen; Gerrit J Jager; Nico Karssemeijer
Accuracy of rigid CT-FDG-PET image registration of the liver.
Physics in medicine and biology 2004;49(23):5393-405.
2004: Chantal P Bleeker-Rovers; Andre J A M van der Ven; Bert Zomer; Lioe-Fee de Geus-Oei; Paul Smits; Frans H M Corstens; Peter P Koopmans; Wim J G Oyen
F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients.
AIDS (London, England) 2004;18(18):2430-2.
2004: Huub J J M Rennen; Chantal P Bleeker-Rovers; Julliëtte E M van Eerd; Cathelijne Frielink; Wim J G Oyen; Frans H M Corstens; Otto Boerman
99mTc-labeled interleukin-8 for scintigraphic detection of pulmonary infections.
Chest 2004;126(6):1954-61.
2004: Mariëtte C A Van Kouwen; Joost P H Drenth; Wim J G Oyen; J H F M de Bruin; M J L Ligtenberg; J J Han Bonenkamp; J H J M van Krieken; Fokko M Nagengast
[18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6456-9.
2004: Julliëtte E M van Eerd; Huub J J M Rennen; Wim J G Oyen; Thomas D Harris; D Scott Edwards; Frans H M Corstens; Otto Boerman
Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene b4 antagonist.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1747-53.
2004: Chantal P Bleeker-Rovers; Frans H M Corstens; Jos W M van der Meer; Wim J G Oyen
Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy.
European journal of nuclear medicine and molecular imaging 2004;31(9):1342-3; author reply 1344.
2004: Adrienne H Brouwers; Peter F A Mulders; Egbert Oosterwijk; Wilhelmina C A M Buijs; Frans H M Corstens; Otto Boerman; Wim J G Oyen
Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):466-77.
2004: Lioe-Fee de Geus-Oei; Julliëtte van Eerd-Vismale; Carla F M Molthoff; Frans H M Corstens; Wim J G Oyen; Otto Boerman
Tracers to monitor the response to chemotherapy: in vitro screening of four radiopharmaceuticals.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):457-65.
2004: Marcel Janssen; Cathelijne Frielink; Ingrid Dijkgraaf; Wim J G Oyen; D Scott Edwards; Shuang Liu; Milind Rajopadhye; L F A G Massuger; Frans H M Corstens; Otto Boerman
Improved tumor targeting of radiolabeled RGD peptides using rapid dose fractionation.
Cancer biotherapy & radiopharmaceuticals 2004;19(4):399-404.
2004: J Roan Spermon; Wim J G Oyen; Simon P Strijk; Christina A Hulsbergen-van de Kaa; J Alfred Witjes
Solitary skull recurrence from stage I seminomatous germ cell tumor of testis.
Urology 2004;64(2):377-9.
2004: Bastiaan Wiering; T J M Ruers; Wim J G Oyen
Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.
Expert review of anticancer therapy 2004;4(4):607-13.
2004: Wim J G Oyen; Johan Bussink; Ad F T M Verhagen; Frans H M Corstens; Gerben P Bootsma
Role of FDG-PET in the diagnosis and management of lung cancer.
Expert review of anticancer therapy 2004;4(4):561-7.
2004: Manuel J Koppe; Robert P Bleichrodt; Annemieke C Soede; Albert A J Verhofstad; David M Goldenberg; Wim J G Oyen; Otto Boerman
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1224-32.
2004: Huub J J M Rennen; Cathelijne Frielink; Ernst Brandt; Sebastian A J Zaat; Otto Boerman; Wim J G Oyen; Frans H M Corstens
Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1217-23.
2004: Ed H M Hartman; jeroen pikkemaat; Jacques J Van Asten; Johan W M Vehof; Arend Heerschap; Wim J G Oyen; Paul H M Spauwen; John A Jansen
Demineralized bone matrix-induced ectopic bone formation in rats: in vivo study with follow-up by magnetic resonance imaging, magnetic resonance angiography, and dual-energy X-ray absorptiometry.
Tissue engineering 2004;10(5-6):747-54.
2004: Ad F T M Verhagen; E Bollen; Vivianne C G Tjan-Heijnen; Gerben P Bootsma; A Hensens; Wim J G Oyen
[The biopsying of at least 5 mediastinal lymph node stations for presurgical staging in patients with a non-small-cell lung carcinoma].
Nederlands tijdschrift voor geneeskunde 2004;148(18):908; author reply 908-9.
2004: Peter Laverman; Martin Béhé; Wim J G Oyen; Peter H G M Willems; Frans H M Corstens; Thomas M Behr; Otto Boerman
Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
Bioconjugate chemistry 2004;15(3):561-8.
2004: Ad F T M Verhagen; Gerben P Bootsma; Vivianne C G Tjan-Heijnen; Gert Jan van der Wilt; A L Cox; M H J Brouwer; Frans H M Corstens; Wim J G Oyen
FDG-PET in staging lung cancer: how does it change the algorithm?
Lung cancer (Amsterdam, Netherlands) 2004;44(2):175-81.
2004: Adrienne H Brouwers; Iris Verel; Julliëtte E M van Eerd; Gerard Visser; Martijn Steffens; Egbert Oosterwijk; Frans H M Corstens; Wim J G Oyen; Guus A M S van Dongen; Otto Boerman
PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):155-63.
2004: Chantal P Bleeker-Rovers; G Jager; Cees J Tack; J W M Van Der Meer; Wim J G Oyen
F-18-fluorodeoxyglucose positron emission tomography leading to a diagnosis of septic thrombophlebitis of the portal vein: description of a case history and review of the literature.
Journal of internal medicine 2004;255(3):419-23.
2004: Adrienne H Brouwers; Julliëtte E M van Eerd; Cathelijne Frielink; Egbert Oosterwijk; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(2):327-37.
2004: Mariëtte C A Van Kouwen; Wim J G Oyen; Fokko M Nagengast; J B M J Jansen; Joost P H Drenth
FDG-PET scanning in the diagnosis of gastrointestinal cancers.
Scandinavian journal of gastroenterology. Supplement 2004;(241):85-92.
2004: Martin Gotthardt; O C Boermann; T M Behr; Martin Béhé; Wim J G Oyen
Development and clinical application of peptide-based radiopharmaceuticals.
Current pharmaceutical design 2004;10(24):2951-63.
2004: Chantal P Bleeker-Rovers; Otto Boerman; Huub J J M Rennen; Frans H M Corstens; Wim J G Oyen
Radiolabeled compounds in diagnosis of infectious and inflammatory disease.
Current pharmaceutical design 2004;10(24):2935-50.
2004: Hans J C Berger; Alexander R Cools; Martin Horstink; Wim J G Oyen; Elisabeth W M Verhoeven; Sieberen van der Werf
Striatal dopamine and learning strategy-an (123)I-FP-CIT SPECT study.
Neuropsychologia 2004;42(8):1071-8.
2004: Wouter V Vogel; Wim J G Oyen; Jelle O Barentsz; Johannes H A M Kaanders; Frans H M Corstens
PET/CT: panacea, redundancy, or something in between?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45 Suppl 1():15S-24S.
2004: Julliëtte E M van Eerd; Peter Laverman; Wim J G Oyen; Thomas D Harris; D Scott Edwards; Charles E Ellars; Frans H M Corstens; Otto Boerman
Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(1):89-93.
2004: Chantal P Bleeker-Rovers; S J H Bredie; Jos W M van der Meer; Frans H M Corstens; Wim J G Oyen
Fluorine 18 fluorodeoxyglucose positron emission tomography in the diagnosis and follow-up of three patients with vasculitis.
The American journal of medicine 2004;116(1):50-3.
2004: Chantal P Bleeker-Rovers; Elisabeth M H A de Kleijn; Frans H M Corstens; Jos W M van der Meer; Wim J G Oyen
Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.
European journal of nuclear medicine and molecular imaging 2004;31(1):29-37.
2003: Julliëtte E M van Eerd; Otto Boerman; Frans H M Corstens; Wim J G Oyen
Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2003;47(4):246-55.
2003: Wim J G Oyen; Luigi Mansi
FDG-PET in infectious and inflammatory disease.
European journal of nuclear medicine and molecular imaging 2003;30(11):1568-70.
2003: Manuel J Koppe; Annemieke C Soede; Wikke Pels; Wim J G Oyen; David M Goldenberg; Robert P Bleichrodt; Otto Boerman
Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin.
International journal of cancer. Journal international du cancer 2003;106(6):965-72.
2003: Andreas A O Eggert; Robbert van der Voort; Ruurd Torensma; Veronique Moulin; Otto Boerman; Wim J G Oyen; Cornelis J A Punt; Heleen Diepstra; Annemiek J de Boer; Carl G Figdor; Gosse J Adema
Analysis of dendritic cell trafficking using EGFP-transgenic mice.
Immunology letters 2003;89(1):17-24.
2003: Chantal P Bleeker-Rovers; S J H Bredie; J W M Van Der Meer; Frans H M Corstens; Wim J G Oyen
F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis.
The Netherlands journal of medicine 2003;61(10):323-9.
2003: Ernst J Postema; Wilhelmina C A M Buijs; Otto Boerman; Wim J G Oyen
Underestimation of absorbed dose to kidney.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(10):1707-8.
2003: Ernst J Postema; Pontus K E Börjesson; Wilhelmina C A M Buijs; Jan C Roos; Henri Marres; Otto Boerman; Remco de Bree; Margreet Lang; Gerd Munzert; Guus A M S van Dongen; Wim J G Oyen
Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(10):1690-9.
2003: Klaas Havenga; David C P Cobben; Wim J G Oyen; S Nienhuijs; Harald J Hoekstra; T J M Ruers; Theo Wobbes
Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003;29(8):662-4.
2003: M L Janssen; W Pels; L F A G Massuger; Wim J G Oyen; Henk Boonstra; Frans H M Corstens; Otto Boerman
Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13(5):607-13.
2003: Ernst J Postema; John M M Raemaekers; Wim J G Oyen; Otto Boerman; C M P W Mandigers; David M Goldenberg; Guus A M S van Dongen; Frans H M Corstens
Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3995S-4002S.
2003: Pontus K E Börjesson; Ernst J Postema; Jan C Roos; David R Colnot; Henri Marres; Mathijs H van Schie; Gerd Stehle; Remco de Bree; Gordon B Snow; Wim J G Oyen; Guus A M S van Dongen
Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3961S-72S.
2003: Adrienne H Brouwers; Wilhelmina C A M Buijs; Egbert Oosterwijk; Otto Boerman; Carola Mala; P H M De Mulder; Frans H M Corstens; Peter F A Mulders; Wim J G Oyen
Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)In: an intrapatient comparison.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3953S-60S.
2003: Frank G van Schaijk; Egbert Oosterwijk; Annemieke C Soede; Wim J G Oyen; William J McBride; Gary L Griffiths; David M Goldenberg; Frans H M Corstens; Otto Boerman
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3880S-5S.
2003: Huub J J M Rennen; Otto Boerman; Wim J G Oyen; Frans H M Corstens
Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(9):1502-9.
2003: Pilar Barrera; Wim J G Oyen; Otto Boerman; P L C M van Riel
Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62(9):825-8.
2003: Adrienne H Brouwers; Cathelijne Frielink; Egbert Oosterwijk; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):539-47.
2003: Ernst J Postema; Cathelijne Frielink; Wim J G Oyen; John M M Raemaekers; David M Goldenberg; Frans H M Corstens; Otto Boerman
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
Cancer biotherapy & radiopharmaceuticals 2003;18(4):525-33.
2003: Frank J A van den Hoogen; Wim J G Oyen
[Diagnostic image (149). A woman with a mass at the base of the tongue. Lingual thyroid].
Nederlands tijdschrift voor geneeskunde 2003;147(30):1455.
2003: Julliëtte E M van Eerd; Wim J G Oyen; Thomas D Harris; Huub J J M Rennen; D Scott Edwards; Shuang Liu; Charles E Ellars; Frans H M Corstens; Otto Boerman
A bivalent leukotriene B(4) antagonist for scintigraphic imaging of infectious foci.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(7):1087-91.
2003: Frederieke M Brouwers; Wim J G Oyen; Otto Boerman; John A Barrett; Freek W A Verheugt; Frans H M Corstens; Jos W M van der Meer
Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis.
Clinical nuclear medicine 2003;28(6):480-4.
2003: Chantal P Bleeker-Rovers; Ruud G L de Sévaux; Henk W van Hamersvelt; Frans H M Corstens; Wim J G Oyen
Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(6):E18-21.
2003: Ernst J Postema; Wim J G Oyen; Otto Boerman; Frans H M Corstens
Administration guidelines for radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-labeled anti-CD20 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):853.
2003: Huub J J M Rennen; Wim J G Oyen; S A Cain; Peter N Monk; Frans H M Corstens; Otto Boerman
Tc-99m-labeled C5a and C5a des Arg74 for infection imaging.
Nuclear medicine and biology 2003;30(3):267-72.
2003: P L Jager; Riemer H J A Slart; F Corstens; Wim J G Oyen; O Hoekstra; J Teule
PET-CT: a matter of opinion?
European journal of nuclear medicine and molecular imaging 2003;30(3):470-1; author reply 471.
2003: Nike M M L Stikkelbroeck; Wim J G Oyen; Gert Jan van der Wilt; Ad R M M Hermus; Barto J Otten
Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia.
The Journal of clinical endocrinology and metabolism 2003;88(3):1036-42.
2003: Otto Boerman; Frank G van Schaijk; Wim J G Oyen; Frans H M Corstens
Pretargeted radioimmunotherapy of cancer: progress step by step.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(3):400-11.
2003: Alfons A den Broeder; Geert J A Wanten; Wim J G Oyen; Ton H J Naber; P L C M van Riel; Pilar Barrera
Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis.
The Journal of rheumatology 2003;30(2):232-7.
2003: Elizabeth H Hoogendoorn; Wim J G Oyen; A P J van Dijk; J W M Van Der Meer
Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2003;9(1):73-6.
2003: I Jolanda M De Vries; Daniëlle J E B Krooshoop; Nicole M Scharenborg; W Joost Lesterhuis; J H S Diepstra; Goos N P van Muijen; Simon P Strijk; T J M Ruers; Otto Boerman; Wim J G Oyen; Gosse J Adema; Cornelis J A Punt; Carl G Figdor
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state.
Cancer research 2003;63(1):12-7.
2002: Marcel Janssen; Wim J G Oyen; L F A G Massuger; Cathelijne Frielink; Ingrid Dijkgraaf; D Scott Edwards; Milind Radjopadhye; Frans H M Corstens; Otto Boerman
Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):641-6.
2002: Dirk M Scharn; Wim J G Oyen; Peter L Klemm; M H W A Wijnen; J Adam vanderVliet
Assessment of prosthetic vascular graft thrombogenicity using the technetium-99m labeled glycoprotein IIb/IIIa receptor antagonist DMP444 in a dog model.
Cardiovascular surgery (London, England) 2002;10(6):566-9.
2002: Barbara S Langenhoff; Wim J G Oyen; GJ Jager; Simon P Strijk; Theo Wobbes; Frans H M Corstens; T J M Ruers
Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4453-8.
2002: Marcel L Janssen; Wim J G Oyen; Ingrid Dijkgraaf; L F A G Massuger; Cathelijne Frielink; D Scott Edwards; Milind Rajopadhye; Henk Boonstra; Frans H M Corstens; Otto Boerman
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Cancer research 2002;62(21):6146-51.
2002: M G Steffens; Peter F A Mulders; Adrienne H Brouwers; Wim J G Oyen
Re: Clinical role of f-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
The Journal of urology 2002;168(5):2127-8.
2002: Stefan Gratz; Huub J J M Rennen; Otto Boerman; Wim J G Oyen; Peter Mast; Thomas M Behr; Frans H M Corstens
99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(7):918-24.
2002: Peter Laverman; Otto Boerman; Frans H M Corstens; Wim J G Oyen
Fluorinated amino acids for tumour imaging with positron emission tomography.
European journal of nuclear medicine and molecular imaging 2002;29(5):681-90.
2002: J Roan Spermon; Lioe-Fee de Geus-Oei; Lambertus A L M Kiemeney; J Alfred Witjes; Wim J G Oyen
The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours.
BJU international 2002;89(6):549-56.
2002: Huub J J M Rennen; Julliëtte E M van Eerd; Wim J G Oyen; Frans H M Corstens; D Scott Edwards; Otto Boerman
Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection.
Bioconjugate chemistry 2002;13(2):370-7.
2002: Adrienne H Brouwers; U Dorr; O Lang; Otto Boerman; Wim J G Oyen; M G Steffens; Egbert Oosterwijk; H G Mergenthaler; H Bihl; Frans H M Corstens
131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study.
Nuclear medicine communications 2002;23(3):229-36.
2002: P Laverman; Otto Boerman; G Storm; Wim J G Oyen
(99m)Tc-labelled Stealth liposomal doxorubicin (Caelyx) in glioblastomas and metastatic brain tumours.
British journal of cancer 2002;86(4):659-61.
2002: Martin J Becker; Els Th M Dams; Siem de Marie; Wim J G Oyen; Otto Boerman; Marcel H A M Fens; Henri A Verbrugh; Irma A J M Bakker-Woudenberg
Scintigraphic imaging using 99mTc-labeled PEG liposomes allows early detection of experimental invasive pulmonary aspergillosis in neutropenic rats.
Nuclear medicine and biology 2002;29(2):177-84.
2002: T J M Ruers; Barbara S Langenhoff; N Neeleman; GJ Jager; Simon P Strijk; Theo Wobbes; Frans H M Corstens; Wim J G Oyen
Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):388-95.
2001: J P Drenth; Fokko M Nagengast; Wim J G Oyen
Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings.
European journal of nuclear medicine 2001;28(12):1766-9.
2001: Ernst J Postema; Otto Boerman; Wim J G Oyen; John M M Raemaekers; Frans H M Corstens
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
European journal of nuclear medicine 2001;28(11):1725-35.
2001: Wim J G Oyen; Otto Boerman; Frans H M Corstens
Animal models of infection and inflammation and their role in experimental nuclear medicine.
Journal of microbiological methods 2001;47(2):151-7.
2001: Otto Boerman; Huub J J M Rennen; Wim J G Oyen; Frans H M Corstens
Radiopharmaceuticals to image infection and inflammation.
Seminars in nuclear medicine 2001;31(4):286-95.
2001: Wim J G Oyen; J Alfred Witjes; Frans H M Corstens
Nuclear medicine techniques for the diagnosis and therapy of prostate carcinoma.
European urology 2001;40(3):294-9.
2001: Otto Boerman; J van Eerd; Wim J G Oyen; Frans H M Corstens
A 3-step pretargeting strategy to image infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(9):1405-11.
2001: Peter Laverman; Els Th M Dams; Gert Storm; Theo Hafmans; Huib Croes; Wim J G Oyen; Frans H M Corstens; Otto Boerman
Microscopic localization of PEG-liposomes in a rat model of focal infection.
Journal of controlled release : official journal of the Controlled Release Society 2001;75(3):347-55.
2001: R M H G Mollen; W P M Hopman; Wim J G Oyen; HH Kuijpers; M A Edelbroek; J B M J Jansen
Effect of subtotal colectomy on gastric emptying of a solid meal in slow-transit constipation.
Diseases of the colon and rectum 2001;44(8):1189-95.
2001: Stefan Gratz; Huub J J M Rennen; Otto Boerman; Wim J G Oyen; P Burma; Frans H M Corstens
(99m)Tc-interleukin-8 for imaging acute osteomyelitis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(8):1257-64.
2001: Otto Boerman; Wim J G Oyen; Frans H M Corstens
Progress in gene therapy: seeing is believing.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(8):1235-7.
2001: Peter Laverman; M G Carstens; Otto Boerman; Els Th M Dams; Wim J G Oyen; Nico van Rooijen; Frans H M Corstens; Gert Storm
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
The Journal of pharmacology and experimental therapeutics 2001;298(2):607-12.
2001: Huub J J M Rennen; Frans H M Corstens; Wim J G Oyen; Otto Boerman
New concepts in infection/inflammation imaging.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2001;45(2):167-73.
2001: Stefan Gratz; Huub J J M Rennen; Otto Boerman; Wim J G Oyen; Frans H M Corstens
Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(6):917-23.
2001: Huub J J M Rennen; J Makarewicz; Wim J G Oyen; Peter Laverman; Frans H M Corstens; Otto Boerman
The effect of molecular weight on nonspecific accumulation of (99m)T-labeled proteins in inflammatory foci.
Nuclear medicine and biology 2001;28(4):401-8.
2001: Lorna E T Stearne; Inge C Gyssens; W H F Goessens; Johan W Mouton; Wim J G Oyen; Jos W M van der Meer; Henri A Verbrugh
In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
Antimicrobial agents and chemotherapy 2001;45(5):1394-401.
2001: Huub J J M Rennen; Otto Boerman; Wim J G Oyen; Frans H M Corstens
Imaging infection/inflammation in the new millennium.
European journal of nuclear medicine 2001;28(2):241-52.
2001: Otto Boerman; Els Th M Dams; Wim J G Oyen; Frans H M Corstens; Gert Storm
Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2001;50(2):55-64.
2001: Huub J J M Rennen; Otto Boerman; Wim J G Oyen; Jos W M van der Meer; Frans H M Corstens
Specific and rapid scintigraphic detection of infection with 99mTc-labeled interleukin-8.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(1):117-23.
2000: Adrienne H Brouwers; Peter Laverman; Otto Boerman; Wim J G Oyen; John A Barrett; Thomas D Harris; D Scott Edwards; Frans H M Corstens
A 99Tcm-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits.
Nuclear medicine communications 2000;21(11):1043-50.
2000: O J M Vogels; J Veltman; Wim J G Oyen; Martin Horstink
Decreased striatal dopamine D2 receptor binding in amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA): D2 receptor down-regulation versus striatal cell degeneration.
Journal of the neurological sciences 2000;180(1-2):62-5.
2000: Otto Boerman; Peter Laverman; Wim J G Oyen; Frans H M Corstens; G Storm
Radiolabeled liposomes for scintigraphic imaging.
Progress in lipid research 2000;39(5):461-75.
2000: Huub J J M Rennen; Otto Boerman; E B Koenders; Wim J G Oyen; Frans H M Corstens
Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): optimization of the conjugation reaction.
Nuclear medicine and biology 2000;27(6):599-604.
2000: Pilar Barrera; CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; P L E M van Lent; L B van de Putte; Frans H M Corstens
Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis.
Rheumatology (Oxford, England) 2000;39(8):870-4.
2000: Otto Boerman; Wim J G Oyen; Frans H M Corstens
Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.
Seminars in nuclear medicine 2000;30(3):195-208.
2000: Peter Laverman; Adrienne H Brouwers; Els Th M Dams; Wim J G Oyen; Gert Storm; Nico van Rooijen; Frans H M Corstens; Otto Boerman
Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose.
The Journal of pharmacology and experimental therapeutics 2000;293(3):996-1001.
2000: Maria Luísa Corvo; Otto Boerman; Wim J G Oyen; J C Jorge; M E M Cruz; Daan J A Crommelin; Gert Storm
Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: in vivo fate and therapeutic activity in an inflammation model.
Pharmaceutical research 2000;17(5):600-6.
2000: Peter Laverman; Samuel Zalipsky; Wim J G Oyen; Els Th M Dams; Gert Storm; Nasreen Mullah; Frans H M Corstens; Otto Boerman
Improved imaging of infections by avidin-induced clearance of 99mTc-biotin-PEG liposomes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):912-8.
2000: Els Th M Dams; MW Nijhof; Otto Boerman; Peter Laverman; Gert Storm; Pieter Buma; J A Lemmens; Jos W M van der Meer; Frans H M Corstens; Wim J G Oyen
Scintigraphic evaluation of experimental chronic osteomyelitis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):896-902.
2000: Wim J G Oyen; Otto Boerman; Frederieke M Brouwers; John A Barrett; Freek W A Verheugt; D J Ruiter; Frans H M Corstens; Jos W M van der Meer
Scintigraphic detection of acute experimental endocarditis with the technetium-99m labelled glycoprotein IIb/IIIa receptor antagonist DMP444.
European journal of nuclear medicine 2000;27(4):392-9.
2000: Wim J G Oyen; C Verhagen; E Saris; W J van den Broek; G F Pieters; F H Corsten
Follow-up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(4):643-6.
2000: Els Th M Dams; Wim J G Oyen; Otto Boerman; Gert Storm; Peter Laverman; P J Kok; Wilhelmina C A M Buijs; H Bakker; Jos W M van der Meer; Frans H M Corstens
99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(4):622-30.
2000: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; Jos W M van der Meer; Frans H M Corstens
Radiolabeled interleukin-8: specific scintigraphic detection of infection within a few hours.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(3):463-9.
2000: Els Th M Dams; Peter Laverman; Wim J G Oyen; Gert Storm; G L Scherphof; Jos W M van der Meer; Frans H M Corstens; Otto Boerman
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
The Journal of pharmacology and experimental therapeutics 2000;292(3):1071-9.
2000: Adrienne H Brouwers; Dirk J de Jong; Els Th M Dams; Wim J G Oyen; Otto Boerman; Peter Laverman; Ton H J Naber; Gert Storm; Frans H M Corstens
Tc-99m-PEG-Liposomes for the evaluation of colitis in Crohn's disease.
Journal of drug targeting 2000;8(4):225-33.
1999: Els Th M Dams; Martin J Becker; Wim J G Oyen; Otto Boerman; Gert Storm; Peter Laverman; Siem de Marie; J W van der Meer; Irma A J M Bakker-Woudenberg; Frans H M Corstens
Scintigraphic imaging of bacterial and fungal infection in granulocytopenic rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2066-72.
1999: MG Steffens; Otto Boerman; P H M De Mulder; Wim J G Oyen; Wilhelmina C A M Buijs; J Alfred Witjes; Wim J M van den Broek; Jeannette C Oosterwijk-Wakka; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10 Suppl):3268s-3274s.
1999: Otto Boerman; MH Kranenborg; Egbert Oosterwijk; G L Griffiths; W J McBride; Wim J G Oyen; Mirjam de Weijert; Jeannette C Oosterwijk-Wakka; H J Hansen; Frans H M Corstens
Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate.
Cancer research 1999;59(17):4400-5.
1999: Andreas A O Eggert; Marco W Schreurs; Otto Boerman; Wim J G Oyen; Annemiek J de Boer; Cornelis J A Punt; Carl G Figdor; Gosse J Adema
Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.
Cancer research 1999;59(14):3340-5.
1999: Maria Luísa Corvo; Otto Boerman; Wim J G Oyen; L van Bloois; M E M Cruz; Daan J A Crommelin; Gert Storm
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis.
Biochimica et biophysica acta 1999;1419(2):325-34.
1999: Els Th M Dams; michel reijnen; Wim J G Oyen; Otto Boerman; Peter Laverman; Gert Storm; Jos W M van der Meer; Frans H M Corstens; H van Goor
Imaging experimental intraabdominal abscesses with 99mTc-PEG liposomes and 99mTc-HYNIC IgG.
Annals of surgery 1999;229(4):551-7.
1999: MG Steffens; Otto Boerman; Wim J G Oyen; P H Kniest; J Alfred Witjes; GO Oosterhof; Geert J L H van Leenders; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy.
Cancer research 1999;59(7):1615-9.
1999: L van der Laan; Wim J G Oyen; E C T H Tan; Albert A J Verhofstad; Thijs Hendriks; R Jan A Goris
A comparison of free radical-induced vascular and skeletal muscle damage in immunocompetent and neutropenic rats.
The Journal of surgical research 1999;82(2):346-52.
1999: Peter Laverman; Els Th M Dams; Wim J G Oyen; Gert Storm; EB Koenders; R Prevost; Jos W M van der Meer; Frans H M Corstens; Otto Boerman
A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(1):192-7.
1998: Otto Boerman; Wim J G Oyen; Frans H M Corstens; Gert Storm
Liposomes for scintigraphic imaging: optimization of in vivo behavior.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1998;42(4):271-9.
1998: Els Th M Dams; Wim J G Oyen; Otto Boerman; Gert Storm; Peter Laverman; EB Koenders; Jos W M van der Meer; Frans H M Corstens
Technetium-99m-labeled liposomes to image experimental colitis in rabbits: comparison with technetium-99m-HMPAO-granulocytes and technetium-99m-HYNIC-IgG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2172-8.
1998: Wilhelmina C A M Buijs; Wim J G Oyen; Els Th M Dams; Otto Boerman; J A Siegel; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
Nuclear medicine communications 1998;19(8):743-51.
1998: CJ van der Laken; Otto Boerman; Wim J G Oyen; Peter Laverman; MT van de Ven; Frans H M Corstens; Jos W M van der Meer
In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions.
The Journal of infectious diseases 1998;177(5):1398-401.
1998: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; Jos W M van der Meer; Frans H M Corstens
Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction.
European journal of nuclear medicine 1998;25(5):535-46.
1998: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; Jos W M van der Meer; Frans H M Corstens
Imaging of infection in rabbits with radioiodinated interleukin-1 (alpha and beta), its receptor antagonist and a chemotactic peptide: a comparative study.
European journal of nuclear medicine 1998;25(4):347-52.
1998: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; J W Ven der Meer; Frans H M Corstens
The kinetics of radiolabelled interleukin-8 in infection and sterile inflammation.
Nuclear medicine communications 1998;19(3):271-81.
1998: Els Th M Dams; Wim J G Oyen; Otto Boerman; RA Claessens; A B Wymenga; Jos W M van der Meer; Frans H M Corstens
Technetium-99m labeled to human immunoglobulin G through the nicotinyl hydrazine derivative: a clinical study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(1):119-24.
1998: Wim J G Oyen; J M Raemaekers; Frans H M Corstens
Acute myelofibrosis mimicking multiple bone metastases on Tc-99m MDP bone imaging.
Clinical nuclear medicine 1998;23(1):1-2.
1997: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; R Chizzonite; Frans H M Corstens; Jos W M van der Meer
Preferential localization of systemically administered radiolabeled interleukin 1alpha in experimental inflammation in mice by binding to the type II receptor.
The Journal of clinical investigation 1997;100(12):2970-6.
1997: Wim J G Oyen; Otto Boerman; Els Th M Dams; Gert Storm; L van Bloois; EB Koenders; U J van Haelst; Jos W M van der Meer; Frans H M Corstens
Scintigraphic evaluation of experimental colitis in rabbits.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1596-600.
1997: L van der Laan; Wim J G Oyen; Albert A J Verhofstad; E C T H Tan; Henk ter Laak; A Gabreels-Festen; Thijs Hendriks; R Jan A Goris
Soft tissue repair capacity after oxygen-derived free radical-induced damage in one hindlimb of the rat.
The Journal of surgical research 1997;72(1):60-9.
1997: MW Nijhof; Wim J G Oyen; A van Kampen; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Hip and knee arthroplasty infection. In-111-IgG scintigraphy in 102 cases.
Acta orthopaedica Scandinavica 1997;68(4):332-6.
1997: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; D Scott Edwards; John A Barrett; Jos W M van der Meer; Frans H M Corstens
Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1310-5.
1997: MW Nijhof; Wim J G Oyen; A van Kampen; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(8):1300-5.
1997: Otto Boerman; Wim J G Oyen; Gert Storm; Maria Luísa Corvo; L van Bloois; Jos W M van der Meer; Frans H M Corstens
Technetium-99m labelled liposomes to image experimental arthritis.
Annals of the rheumatic diseases 1997;56(6):369-73.
1997: MH Kranenborg; Wim J G Oyen; Frans H M Corstens; Egbert Oosterwijk; Jos W M van der Meer; Otto Boerman
Rapid imaging of experimental infection with technetium-99m-DTPA after anti-DTPA monoclonal antibody priming.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(6):901-6.
1997: MG Steffens; Otto Boerman; Jeannette C Oosterwijk-Wakka; GO Oosterhof; J Alfred Witjes; EB Koenders; Wim J G Oyen; Wilhelmina C A M Buijs; Frans M J Debruyne; Frans H M Corstens; Egbert Oosterwijk
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1529-37.
1997: L van der Laan; P J Kapitein; Wim J G Oyen; Albert A J Verhofstad; Thijs Hendriks; R Jan A Goris
A novel animal model to evaluate oxygen derived free radical damage in soft tissue.
Free radical research 1997;26(4):363-72.
1997: Otto Boerman; Wim J G Oyen; L van Bloois; EB Koenders; Jos W M van der Meer; Frans H M Corstens; Gert Storm
Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(3):489-93.
1997: GA Nieuwenhuijzen; MF Knapen; Wim J G Oyen; Thijs Hendriks; F H Corstens; R Jan A Goris
Organ damage is preceded by changes in protein extravasation in an experimental model of multiple organ dysfunction syndrome.
Shock (Augusta, Ga.) 1997;7(2):98-104.
1996: R M Perenboom; P Beckers; Jos W M van der Meer; A C Van Schijndel; Wim J G Oyen; Frans H M Corstens; Robert W Sauerwein
Pro-inflammatory cytokines in lung and blood during steroid-induced Pneumocystis carinii pneumonia in rats.
Journal of leukocyte biology 1996;60(6):710-5.
1996: RA Claessens; EB Koenders; Wim J G Oyen; Frans H M Corstens
Retention of technetium-99m in infectious foci in rats after release from technetium-99m labelled human non-specific polyclonal immunoglobulin G: a dual-label study with hydrazinonicotinamido and iminothiolano immunoglobulin.
European journal of nuclear medicine 1996;23(11):1536-9.
1996: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection.
European journal of nuclear medicine 1996;23(11):1531-5.
1996: Wim J G Oyen; Otto Boerman; Gert Storm; L van Bloois; EB Koenders; Daan J A Crommelin; Jos W M van der Meer; Frans H M Corstens
Labelled Stealth liposomes in experimental infection: an alternative to leukocyte scintigraphy?
Nuclear medicine communications 1996;17(9):742-8.
1996: Wim J G Oyen; Otto Boerman; Gert Storm; L van Bloois; EB Koenders; RA Claessens; R M Perenboom; Daan J A Crommelin; Jos W M van der Meer; Frans H M Corstens
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(8):1392-7.
1996: Wim J G Oyen; Otto Boerman; R Subramanian; EB Koenders; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Biodistribution of 111In-labelled IgG and IgM in experimental infection.
Nuclear medicine communications 1996;17(7):616-20.
1996: Wim J G Oyen; Otto Boerman; CJ van der Laken; Jos W M van der Meer; Frans H M Corstens
Macrophage targeting in experimental arthritis.
European journal of nuclear medicine 1996;23(6):727-9.
1996: Wim J G Oyen; Otto Boerman; CJ van der Laken; RA Claessens; Jos W M van der Meer; Frans H M Corstens
The uptake mechanisms of inflammation- and infection-localizing agents.
European journal of nuclear medicine 1996;23(4):459-65.
1996: RA Claessens; Otto Boerman; EB Koenders; Wim J G Oyen; Jos W M van der Meer; Frans H M Corstens
Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations.
European journal of nuclear medicine 1996;23(4):414-21.
1996: Wim J G Oyen; J Albert M Lemmens; RA Claessens; Jim R Van Horn; Tom J J H Slooff; Frans H M Corstens
Nuclear arthrography: combined scintigraphic and radiographic procedure for diagnosis of total hip prosthesis loosening.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):62-70.
1995: CJ van der Laken; Otto Boerman; Wim J G Oyen; MT van de Ven; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model.
European journal of nuclear medicine 1995;22(11):1249-55.
1995: Wim J G Oyen; A M van Oort; R B Tanke; G J van Mill; W R Aengevaeren; Frans H M Corstens
Pulmonary perfusion after endovascular stenting of pulmonary artery stenosis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(11):2006-8.
1995: R M Perenboom; Wim J G Oyen; A C van Schijndel; P Beckers; Frans H M Corstens; Jos W M van der Meer
Serial indium-111-labelled IgG biodistribution in rat Pneumocystis carinii pneumonia: a tool to monitor the course and severity of the infection.
European journal of nuclear medicine 1995;22(10):1129-32.
1995: Otto Boerman; Gert Storm; Wim J G Oyen; L van Bloois; Jos W M van der Meer; RA Claessens; Daan J A Crommelin; Frans H M Corstens
Sterically stabilized liposomes labeled with indium-111 to image focal infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(9):1639-44.
1995: Wim J G Oyen; Frans H M Corstens
Scintigraphic techniques for delineation of infection and inflammation.
British journal of hospital medicine 1995;54(2-3):75-80.
1995: A M van Oort; R B Tanke; Wim J G Oyen; G J van Mill; W R Aengevaeren
[Endovascular stent in the treatment of residual pulmonary stenosis in patients operated on for congenital heart defects; initial results].
Nederlands tijdschrift voor geneeskunde 1995;139(23):1182-7.
1995: Wim J G Oyen; A H Mudde; W J van den Broek; Frans H M Corstens
Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(4):613-5.
1995: RA Claessens; EB Koenders; Otto Boerman; Wim J G Oyen; G F Borm; Jos W M van der Meer; Frans H M Corstens
Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci.
European journal of nuclear medicine 1995;22(3):212-9.
1994: Wim J G Oyen; Otto Boerman; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Is somatostatin receptor scintigraphy suited to detection of acute infectious disease?
Nuclear medicine communications 1994;15(4):289-93.
1993: Wim J G Oyen; I E Arntz; R M Claessens; Jos W M van der Meer; Frans H M Corstens; R J Goris
Reflex sympathetic dystrophy of the hand: an excessive inflammatory response?
Pain 1993;55(2):151-7.
1993: Frans H M Corstens; Wim J G Oyen; W S Becker
Radioimmunoconjugates in the detection of infection and inflammation.
Seminars in nuclear medicine 1993;23(2):148-64.
1993: Wim J G Oyen; Wilhelmina C A M Buijs; A van Kampen; EB Koenders; RA Claessens; Frans H M Corstens
Intraoperative bone and bone marrow sampling: a simple method for accurate measurement of uptake of radiopharmaceuticals in bone and bone marrow.
Nuclear medicine communications 1993;14(2):112-6.
1992: Wim J G Oyen; PM Netten; J Albert M Lemmens; RA Claessens; J A Lutterman; J A van der Vliet; R J Goris; Jos W M van der Meer; Frans H M Corstens
Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(7):1330-6.
1992: Wim J G Oyen; RA Claessens; Jos W M van der Meer; Robert Rubin; Harry W Strauss; Frans H M Corstens
Indium-111-labeled human nonspecific immunoglobulin G: a new radiopharmaceutical for imaging infectious and inflammatory foci.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14(5):1110-8.
1992: Wim J G Oyen; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Biodistribution and kinetics of radiolabeled proteins in rats with focal infection.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(3):388-94.
1992: Wim J G Oyen; RA Claessens; J M Raemaekers; B E de Pauw; Jos W M van der Meer; Frans H M Corstens
Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):61-8.
1992: Wim J G Oyen; Jim R Van Horn; RA Claessens; Tom J J H Slooff; Jos W M van der Meer; Frans H M Corstens
Diagnosis of bone, joint, and joint prosthesis infections with In-111-labeled nonspecific human immunoglobulin G scintigraphy.
Radiology 1992;182(1):195-9.
1991: Wim J G Oyen; RA Claessens; Jos W M van der Meer; Frans H M Corstens
Detection of subacute infectious foci with indium-111-labeled autologous leukocytes and indium-111-labeled human nonspecific immunoglobulin G: a prospective comparative study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(10):1854-60.
1990: Wim J G Oyen; RA Claessens; J R van Horn; Jos W M van der Meer; Frans H M Corstens
Scintigraphic detection of bone and joint infections with indium-111-labeled nonspecific polyclonal human immunoglobulin G.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(4):403-12.